NAV

6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One

Identification

Generic Name
6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One
DrugBank Accession Number
DB03507
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
3D
Similar Structures
Weight
Average: 456.538
Monoisotopic: 456.092596528
Chemical Formula
C21H20N4O4S2
Synonyms
Not Available
Poor quality drug data slowing you down?
Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.
Download eBook
Poor quality drug data slowing you down?
Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UTumor necrosis factor receptor superfamily member 1ANot AvailableHumans
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as nitrobenzenes. These are compounds containing a nitrobenzene moiety, which consists of a benzene ring with a carbon bearing a nitro group.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Nitrobenzenes
Direct Parent
Nitrobenzenes
Alternative Parents
Thienopyrroles / 2,3,5-trisubstituted thiophenes / Nitroaromatic compounds / Morpholines / Pyrroles / Heteroaromatic compounds / Trialkylamines / Thioureas / Amino acids and derivatives / Propargyl-type 1,3-dipolar organic compounds
show 7 more
Substituents
2,3,5-trisubstituted thiophene / Allyl-type 1,3-dipolar organic compound / Amine / Amino acid or derivatives / Aromatic heteropolycyclic compound / Azacycle / C-nitro compound / Carboxylic acid derivative / Dialkyl ether / Ether
show 25 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
C-nitro compound, morpholines, thienopyrroloimidazole (CHEBI:40211)
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
Not Available
InChI Key
UXGUZFZBZPPZGL-UHFFFAOYSA-N
InChI
InChI=1S/C21H20N4O4S2/c26-20-17-13-19-16(12-18(31-19)14-3-1-4-15(11-14)25(27)28)24(17)21(30)23(20)6-2-5-22-7-9-29-10-8-22/h1,3-4,11-13H,2,5-10H2
IUPAC Name
10-[3-(morpholin-4-yl)propyl]-4-(3-nitrophenyl)-11-sulfanylidene-5-thia-1,10-diazatricyclo[6.3.0.0^{2,6}]undeca-2(6),3,7-trien-9-one
SMILES
[O-][N+](=O)C1=CC(=CC=C1)C1=CC2=C(S1)C=C1N2C(=S)N(CCCN2CCOCC2)C1=O

References

General References
Not Available
PubChem Compound
4470566
PubChem Substance
46507367
ChemSpider
3668969
ZINC
ZINC000012503715
PDBe Ligand
703
PDB Entries
1ft4

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.0214 mg/mLALOGPS
logP4.08ALOGPS
logP3.29Chemaxon
logS-4.3ALOGPS
pKa (Strongest Basic)6.52Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count5Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area80.85 Å2Chemaxon
Rotatable Bond Count6Chemaxon
Refractivity122.12 m3·mol-1Chemaxon
Polarizability48.49 Å3Chemaxon
Number of Rings5Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleYesChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9436
Blood Brain Barrier+0.7913
Caco-2 permeable-0.5957
P-glycoprotein substrateNon-substrate0.5061
P-glycoprotein inhibitor IInhibitor0.5981
P-glycoprotein inhibitor IIInhibitor0.5697
Renal organic cation transporterNon-inhibitor0.6489
CYP450 2C9 substrateNon-substrate0.8076
CYP450 2D6 substrateNon-substrate0.8008
CYP450 3A4 substrateSubstrate0.5851
CYP450 1A2 substrateNon-inhibitor0.7963
CYP450 2C9 inhibitorInhibitor0.6788
CYP450 2D6 inhibitorNon-inhibitor0.915
CYP450 2C19 inhibitorNon-inhibitor0.5206
CYP450 3A4 inhibitorNon-inhibitor0.5498
CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.8765
Ames testAMES toxic0.7279
CarcinogenicityNon-carcinogens0.7698
BiodegradationNot ready biodegradable0.9672
Rat acute toxicity2.5381 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Strong inhibitor0.5892
hERG inhibition (predictor II)Inhibitor0.5955
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-194.92123
predicted
DeepCCS 1.0 (2019)
[M+H]+197.3168
predicted
DeepCCS 1.0 (2019)
[M+Na]+203.28865
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Details1. Tumor necrosis factor receptor superfamily member 1A
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Tumor necrosis factor-activated receptor activity
Specific Function
Receptor for TNFSF2/TNF-alpha and homotrimeric TNFSF1/lymphotoxin-alpha. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC...
Gene Name
TNFRSF1A
Uniprot ID
P19438
Uniprot Name
Tumor necrosis factor receptor superfamily member 1A
Molecular Weight
50494.3 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
  3. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52